Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands

Daniel R. Morales; Steve V. Morant; Thomas M. MacDonald; Isla S. Mackenzie; Alexander S.F. Doney; Lyn Mitchell; Marion Bennie; Chris Robertson; Jesper Hallas; Anton Pottegard; Martin Thomsen Ernst; Li Wei; Lizzie Nicholson; Carole Morris; Ron M.C. Herings; Jetty A. Overbeek; Elisabeth Smits; Robert W.V. Flynn

doi:10.1002/pds.4955

Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands

Daniel R. Morales, Steve V. Morant, Thomas M. MacDonald, Isla S. Mackenzie, Alexander S.F. Doney, Lyn Mitchell, Marion Bennie, Chris Robertson, Jesper Hallas, Anton Pottegard, Martin Thomsen Ernst, Li Wei, Lizzie Nicholson, Carole Morris, Ron M.C. Herings, Jetty A. Overbeek, Elisabeth Smits, Robert W.V. Flynn

科研成果: 期刊稿件 › 文章 › 同行评审

12 引用（Scopus）

源语言	英语
页（从-至）	296-305
页数	10
期刊	Pharmacoepidemiology and Drug Safety
卷	29
期	3
DOI	https://doi.org/10.1002/pds.4955
出版状态	已出版 - 3月 1 2020
已对外发布	是

!!!ASJC Scopus Subject Areas

药学（医学）
流行病学

访问文件

10.1002/pds.4955

其它文件与链接

引用此

Morales, D. R., Morant, S. V., MacDonald, T. M., Mackenzie, I. S., Doney, A. S. F., Mitchell, L., Bennie, M., Robertson, C., Hallas, J., Pottegard, A., Ernst, M. T., Wei, L., Nicholson, L., Morris, C., Herings, R. M. C., Overbeek, J. A., Smits, E., & Flynn, R. W. V. (2020). Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands. Pharmacoepidemiology and Drug Safety, 29(3), 296-305. https://doi.org/10.1002/pds.4955

Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands. / Morales, Daniel R.; Morant, Steve V.; MacDonald, Thomas M. 等.
在: Pharmacoepidemiology and Drug Safety, 卷 29, 号码 3, 01.03.2020, 页码 296-305.

科研成果: 期刊稿件 › 文章 › 同行评审

Morales, DR, Morant, SV, MacDonald, TM, Mackenzie, IS, Doney, ASF, Mitchell, L, Bennie, M, Robertson, C, Hallas, J, Pottegard, A, Ernst, MT, Wei, L, Nicholson, L, Morris, C, Herings, RMC, Overbeek, JA, Smits, E & Flynn, RWV 2020, 'Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands', Pharmacoepidemiology and Drug Safety, 卷 29, 号码 3, 页码 296-305. https://doi.org/10.1002/pds.4955

@article{fb0170299d5b4d9a931b4fca9b395d98,

title = "Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands",

keywords = "diclofenac, impact, pharmacoepidemiology, pharmacovigilance, prescribing, regulation",

author = "Morales, {Daniel R.} and Morant, {Steve V.} and MacDonald, {Thomas M.} and Mackenzie, {Isla S.} and Doney, {Alexander S.F.} and Lyn Mitchell and Marion Bennie and Chris Robertson and Jesper Hallas and Anton Pottegard and Ernst, {Martin Thomsen} and Li Wei and Lizzie Nicholson and Carole Morris and Herings, {Ron M.C.} and Overbeek, {Jetty A.} and Elisabeth Smits and Flynn, {Robert W.V.}",

note = "Publisher Copyright: {\textcopyright} 2020 The Authors. Pharmacoepidemiology and Drug Safety published by John Wiley & Sons Ltd.",

year = "2020",

month = mar,

day = "1",

doi = "10.1002/pds.4955",

language = "English",

volume = "29",

pages = "296--305",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "John Wiley and Sons Ltd",

number = "3",

}

TY - JOUR

T1 - Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands

AU - Morales, Daniel R.

AU - Morant, Steve V.

AU - MacDonald, Thomas M.

AU - Mackenzie, Isla S.

AU - Doney, Alexander S.F.

AU - Mitchell, Lyn

AU - Bennie, Marion

AU - Robertson, Chris

AU - Hallas, Jesper

AU - Pottegard, Anton

AU - Ernst, Martin Thomsen

AU - Wei, Li

AU - Nicholson, Lizzie

AU - Morris, Carole

AU - Herings, Ron M.C.

AU - Overbeek, Jetty A.

AU - Smits, Elisabeth

AU - Flynn, Robert W.V.

PY - 2020/3/1

Y1 - 2020/3/1

KW - diclofenac

KW - impact

KW - pharmacoepidemiology

KW - pharmacovigilance

KW - prescribing

KW - regulation

UR - http://www.scopus.com/inward/record.url?scp=85078041121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078041121&partnerID=8YFLogxK

U2 - 10.1002/pds.4955

DO - 10.1002/pds.4955

M3 - Article

C2 - 31899936

AN - SCOPUS:85078041121

SN - 1053-8569

VL - 29

SP - 296

EP - 305

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - 3

ER -

Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此